Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway
Author:
Affiliation:
1. Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, P.R. China
2. The Second Department of Respiratory, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, P.R. China
Publisher
Spandidos Publications
Subject
Genetics,General Medicine
Reference37 articles.
1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
2. Opportunities and challenges of kava in lung cancer prevention;Freeman;Int J Mol Sci,2023
3. Spotlight on lorlatinib and its potential in the treatment of NSCLC: The evidence to date;Akamine;Onco Targets Ther,2018
4. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC;Chang;Lung cancer,2011
5. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-11
2. Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease;Diabetes, Obesity and Metabolism;2024-09-04
3. Curcumin suppresses copper accumulation in non-small cell lung cancer by binding ATOX1;BMC Pharmacology and Toxicology;2024-08-21
4. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3